Language selection

Search

2009-04-20 - Male - 41 Years old

322218

Adverse reaction report number 322218
Latest AER version number 1
Market authorization holder AER number SPV1200900648
Initial received date 2009-04-20
Latest received date 2009-05-07
Age 41 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Consumer Or Other Non Health Professional
Source of report MAH
Report outcome Unknown
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRSuspectUnknown100 Milligram every 1 Day(s) Product used for unknown indication
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectUnknown75 Milligram every 1 Day(s) Product used for unknown indication
LITHIUMNOT SPECIFIEDConcomitantUnknown
SEROQUELTABLETConcomitantUnknown
WELLBUTRINTABLET (EXTENDED-RELEASE)ConcomitantUnknown

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Arthralgia
Drug ineffective
Inappropriate schedule of product administration
Meniscus injury
Prescribed overdose
Date modified: